Abstract：【Objective】To summarize the experience of PTCD treatment for hilar cholangiocarcinoma in Xuanwu Hospital of Capital Medical University in recent 5 years. 【Methods】 The clinical data of 86 patients with hilar cholangiocarcinoma treated with ultrasound-guided PTCD in Xuanwu Hospital of Capital Medical University from January 2015 to October 2019 were retrospectively analyzed. The operation related conditions and postoperative complications were recorded. The liver function indexes including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), glutamyltransferase (GGT), total bilirubin (TBIL) and direct bilirubin (DBIL) were compared before and 2 weeks after operation.【Results】In this study, 86 patients underwent 108 times of puncture, including 76 cases of left lobe bile duct and 32 cases of right lobe bile duct,there were 22 cases of left and right bile ducts punctured at the same time. The first puncture success rate was 77.78% (84/108), the total technical success rate was 90.74% (98/108), and the clinical success rate was 86.05% (74/86). Postoperative bile duct bleeding occurred in 12 cases (13.95%), biliary tract infection and peritonitis in 32 cases (37.21%), and drainage tube shedding in 6 cases (6.98%). After operation, 22 patients with jaundice were treated with radical or palliative resection. 64 patients who could not be resected were discharged with catheter. The serum levels of alt, GGT, ALP, TBIL and DBIL were significantly lower than those before operation (P<0.05).【Conclusion】 Ultrasound guided PTCD is an important treatment for patients with hilar cholangiocarcinoma. Simple biliary drainage can improve the liver function, reduce jaundice and improve the quality of life of patients,which has the promotion significance in the basic level hospital.
江华, 王炫均, 王悦华, 刘东斌. 超声引导下PTCD治疗肝门部胆管癌的临床疗效观察[J]. 医学临床研究, 2020, 37(11): 1625-1627.
JIANG Hua, WANG Xuan-jun, WANG Yue-hua, et al. Clinical Efficacy of Ultrasound-guided PTCD in the Treatment of Hilar Cholangiocarcinoma. JOURNAL OF CLINICAL RESEARCH, 2020, 37(11): 1625-1627.
[1] Kim GH, Ryoo SK, Park JK, et al. Risk Factors for Pancreatitis and cholecystitis after endoscopic biliary stenting in patients with malignant extrahepatic bile duct obstruction[J].Clin Endosc,2019,52(6):598-605.
[2] Bernon MM. Distal malignant biliary obstruction: a prospective randomised trial comparing plastic and uncovered self-expanding metal stents in the palliation of symptomatic jaundice[J].S Afr J Surg,2018,56(1):30-34.
[3] Westwood DA, Fernando C, Connor SJ. Internal-external percutaneous transhepatic biliary drainage for malignant biliary obstruction: a retrospective analysis[J].J Med Imaging Radiat Oncol,2010,54(2):108-110.
[4] Tang Z, Yang Y, Meng W, et al. Best option for preoperative biliary drainage in Klatskin tumor: A systematic review and meta-analysis[J].Medicine (Baltimore),2017,96(43):e8372.
[5] Ignee A, Cui X, Schuessler G, et al. Percutaneous transhepatic cholangiography and drainage using extravascular contrast enhanced ultrasound[J].Z Gastroenterol,2015,53(5):385-390.
[6] 江华, 王悦华. 肝门部胆管癌围手术期处理要点[J].临床肝胆病杂志, 2019,35(7): 1644-1647.
[7] Khashab MA, Valeshabad AK, Afghani E, et al. A comparative evaluation of EUS-guided biliary drainage and percutaneous drainage in patients with distal malignant biliary obstruction and failed ERCP[J].Dig Dis Sci,2015,60(2):557-565.
[8] Lee TH, Choi JH, Park dH, et al. Similar efficacies of endoscopic ultrasound-guided transmural and percutaneous drainage for malignant distal biliary obstruction[J].Clin Gastroenterol Hepatol,2016,14(7):1011-1019.
[9] Nennstiel S, Weber A, Frick G, et al. Drainage-related complications in percutaneous transhepatic biliary drainage: an analysis over 10 years[J].J Clin Gastroenterol,2015,49(9):764-770.
[10] Téllez- vila FI. Biliary drainage in patients with failed ercp: percutaneous versus EUS-guided drainage[J].Surg Laparosc Endosc Percutan Tech,2018,28(3):183-187.
2020, Vol. 37 
